These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 8137760)

  • 1. Characterization of the 2-deoxyglucose effect on the adrenocortical axis.
    Weidenfeld J; Corcos AP; Wohlman A; Feldman S
    Endocrinology; 1994 Apr; 134(4):1924-31. PubMed ID: 8137760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle.
    Weidenfeld J; Itzik A; Feldman S
    Brain Res; 1997 Apr; 754(1-2):187-94. PubMed ID: 9134975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitary-adrenocortical axis.
    Feldman S; Weidenfeld J
    J Neural Transm (Vienna); 1997; 104(6-7):633-42. PubMed ID: 9444563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid feedback regulation of adrenocortical responses to neural stimuli: role of CRF-41 and corticosteroid type I and type II receptors.
    Weidenfeld J; Feldman S
    Neuroendocrinology; 1993 Jul; 58(1):49-56. PubMed ID: 8264855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the effect of Mycoplasma fermentans on the hypothalamo-pituitary-adrenal axis.
    Wohlman A; Gallily R; Yirmiya R; Weidenfeld J
    Neuroendocrinology; 1997 Sep; 66(3):221-8. PubMed ID: 9380280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in responsiveness of the hypothalamic-pituitary-adrenocortical axis to 2-deoxy-D-glucose in developing rats.
    Widmaier EP
    Endocrinology; 1990 Jun; 126(6):3116-23. PubMed ID: 2161749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses.
    Feldman S; Newman ME; Gur E; Weidenfeld J
    Neuroreport; 1998 Jun; 9(9):2007-9. PubMed ID: 9674583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the adrenocortical axis by surgical stress: involvement of central norepinephrine and interleukin-1.
    DeKeyser FG; Leker RR; Weidenfeld J
    Neuroimmunomodulation; 2000; 7(4):182-8. PubMed ID: 10810250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adrenalectomy and corticosterone replacement on the hypothalamic-pituitary response to neural stimuli.
    Weidenfeld J; Feldman S
    Brain Res; 2000 Sep; 877(1):73-8. PubMed ID: 10980245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation.
    Bradbury MJ; Akana SF; Dallman MF
    Endocrinology; 1994 Mar; 134(3):1286-96. PubMed ID: 8119168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTH and corticosterone secretion following 2-deoxyglucose administration in intact and in hypothalamic deafferentated male rats.
    Weidenfeld J; Siegel RA; Corcos AP; Heled V; Conforti N; Chowers I
    Brain Res; 1984 Jul; 305(1):109-13. PubMed ID: 6331594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats.
    Buwalda B; de Boer SF; Schmidt ED; Felszeghy K; Nyakas C; Sgoifo A; Van der Vegt BJ; Tilders FJ; Bohus B; Koolhaas JM
    J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41.
    Feldman S; Weidenfeld J
    Brain Res Bull; 1998; 45(4):389-93. PubMed ID: 9527013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.